Trial Profile
Clinical Trials Insight: 700028282
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 May 2011
Price :
$35
*
At a glance
- Drugs AR 9281 (Primary)
- Indications Hypertension; Metabolic syndrome; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 08 Nov 2007 New trial record.